Related Experiment Video
Updated: Jul 7, 2025
06:43
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
12.2K
Role of APOE in glaucoma
1Eye School of Chengdu University of TCM, Chengdu City, Sichuan province, China.
Biochemical and Biophysical Research Communications
|December 25, 2023
Summary
The Apolipoprotein E (APOE) gene influences glaucoma risk. Specific APOE alleles, like APOE4, may protect retinal ganglion cells (RGCs), while others increase RGC death, suggesting targeted APOE therapies for glaucoma.
Area of Science:
- Ophthalmology
- Neuroscience
- Genetics
Background:
- Glaucoma is a leading cause of irreversible blindness due to progressive retinal ganglion cell (RGC) loss.
- No current treatments can directly enhance RGC survival.
- The Apolipoprotein E (APOE) gene is implicated in neurodegenerative diseases, including those affecting the eye.
Purpose of the Study:
- To review the role of different Apolipoprotein E (APOE) alleles in glaucoma pathogenesis.
- To explore the potential of targeting APOE for neuroprotection in glaucoma.
Main Methods:
- Literature review of studies investigating APOE gene variants and their association with glaucoma.
- Analysis of the mechanistic impact of APOE alleles on RGC survival and optic nerve damage.
Main Results:
- APOE4 and APOE gene deletion (APOE-/-) appear to reduce RGC loss in glaucoma.
- APOE3 and the presence of APOE genes (APOE+/+) are associated with increased RGC death and glaucoma risk.
- The effect of APOE2 on glaucoma remains unclear.
Conclusions:
- Different APOE alleles exhibit varying effects on glaucoma progression and RGC survival.
- Targeted modulation of APOE may represent a novel therapeutic strategy for preventing RGC loss in glaucoma.
More Related Videos
Related Concept Videos
01:25Glaucoma: Overview
577
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
577
01:25Aquaporins
4.9K
Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.
4.9K
01:27Open Angle Glaucoma: Treatment
453
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
453
01:11Genetic Lingo
102.8K
Overview
102.8K
01:26Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
01:28Angle Closure Glaucoma: Treatment
508
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
508